• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN FXD CURVE ACCESS SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN FXD CURVE ACCESS SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number M635TU80010
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Non specific EKG/ECG Changes (1817); Heart Block (4444)
Date of Event 12/07/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that heart block occurred.A left atrial appendage (laa) closure procedure was performed using a watchman flx laa closure device with delivery system (wds), a watchman fxd curve access system (was), and versacross connect system.Following the removal of the versacross dilator, st elevation was noted and 2:1 heart block occurred.Medication was administered and a temporary pacemaker was placed.A coronary angiogram identified diminished right ventricle function with no evidence of an air embolism.The patient stabilized and cardiac function was restored.The closure device was successfully implanted, and the procedure concluded.During recovery, the patient passed all neurological examinations.No further patient complications were reported.The patient fully recovered and was discharged one day post index procedure.
 
Additional Manufacturer Narrative
This report is being filed to correct the model number and unique identifier (udi) # in response to an fda request.
 
Event or Problem Description
It was reported that heart block occurred.A left atrial appendage (laa) closure procedure was performed using a watchman flx laa closure device with delivery system (wds), a watchman fxd curve access system (was), and versacross connect system.Following the removal of the versacross dilator, st elevation was noted and 2:1 heart block occurred.Medication was administered and a temporary pacemaker was placed.A coronary angiogram identified diminished right ventricle function with no evidence of an air embolism.The patient stabilized and cardiac function was restored.The closure device was successfully implanted, and the procedure concluded.During recovery, the patient passed all neurological examinations.No further patient complications were reported.The patient fully recovered and was discharged one day post index procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN FXD CURVE ACCESS SYSTEM
Common Device Name
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18327143
Report Number2124215-2023-70353
Device Sequence Number7437946
Product Code DQY
UDI-Device Identifier00191506013806
UDI-Public(01)00191506013806(17)260320(10)31275299
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K212228
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/20/2026
Device Model NumberM635TU80010
Device Catalogue NumberM635TU80010
Device Lot Number0031275299
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 12/07/2023
Supplement Date Received by Manufacturer06/12/2024
Initial Report FDA Received Date12/14/2023
Supplement Report FDA Received Date07/02/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/21/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age78 YR
Patient SexMale
-
-